Quarterly report pursuant to Section 13 or 15(d)

Valent Technologies, LLC

v3.6.0.2
Valent Technologies, LLC
6 Months Ended
Dec. 31, 2016
Valent Technologies, LLC [Abstract]  
Valent Technologies, LLC
3 Valent Technologies, LLC

 

On December 31, 2014, the Company entered into an exchange agreement (the “Valent Exchange Agreement”) with Valent Technologies, LLC (“Valent”), an entity owned by Dr. Dennis Brown, the Company’s Chief Scientific Officer and director, and DelMar (BC). Pursuant to the Valent Exchange Agreement, Valent exchanged its loan payable in the outstanding amount of $278,530 (including aggregate accrued interest to December 31, 2014 of $28,530), issued to Valent by DelMar (BC), for 278,530 shares of the Company’s Series A Preferred Stock. The Series A Preferred Stock has a stated value of $1.00 per share (the “Series A Stated Value”) and is not convertible into common stock. The holder of the Series A Preferred Stock is entitled to dividends at the rate of 3% of the Series A Stated Value per year, payable quarterly in arrears.

 

For the three months ended December 31, 2016 and 2015 respectively, the Company recorded $2,089 related to the dividend payable to Valent. For the six months ended December 31, 2016 and 2015 respectively, the Company recorded $4,178 related to the dividend payable to Valent. The dividends have been recorded as a direct increase in accumulated deficit.